Luminor Capital

Capital C Corporation is a Singapore-based financial services provider that leverages fintech innovations to serve the underbanked population in Singapore. It offers accessible credit solutions such as personal loans, business loans, and auto financing, utilizing proprietary credit scoring methodologies.

PT Adiwisista Finansial Teknologi operates in the financial services industry, focusing on leveraging technology to offer innovative solutions. Established in 2018, the company has grown to employ around 50 individuals dedicated to enhancing financial accessibility and efficiency. It has engaged in strategic partnerships, such as with Salvatore Financial for securities issuance and with Bank SMBC Indonesia for loan channeling. It oversees Danai.id, a platform under its umbrella, which has secured operational licensing from Indonesia's Financial Services Authority (OJK). The company's commitment to integrating technology with financial services is evident in its efforts to streamline processes and offer financial products that cater to the evolving needs of its clients.

Founded in 2014, ayondo is a FinTech company specializing in social trading technology. It connects self-directed investors and trading strategy providers on its platform, enabling real-time signal execution. The company also offers tailored solutions for asset managers in the institutional sector.

Founded in 2014, ayondo is a FinTech company specializing in social trading technology. It connects self-directed investors and trading strategy providers on its platform, enabling real-time signal execution. The company also offers tailored solutions for asset managers in the institutional sector.

TriReme Medical, Inc. is a privately held medical device company located in Pleasanton, California, founded in 2005. The company specializes in the development, manufacturing, and distribution of advanced therapeutic technologies aimed at treating complex vascular diseases, particularly coronary artery disease (CAD) and peripheral vascular disease. TriReme Medical focuses on creating innovative stent and balloon therapies tailored for challenging anatomical scenarios, such as bifurcations, addressing significant clinical needs in these areas. By providing physicians with differentiated devices, the company aims to enhance patient outcomes in complex coronary and peripheral interventions.